08 October 2025
08 October 2025
MapLight’s public listing follows peer schizophrenia specialist LB Pharma’s $285m IPO last month.
The CDC no longer recommends routine Covid-19 booster immunisation or the combined use of the varicella and MMR jabs.
New Enterprise Associates led the investment round, with contributions from newcomer Eli Lilly & Company, among others.
GlobalData predicts that Lilly’s Omvoh will bring in $1.12bn in 2031.
The partnership will harness AI modelling techniques to determine the ideal receptor binding profiles for new compounds.
The proceeds will be used to further the development of NP-MP1 candidate through IND-enabling trials.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
